Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT02312856
Brief Summary:
This study is designed to evaluate the safety of the PulseRider in patients undergoing treatment for bifurcation basilar or carotid terminus aneurysms.
Detailed Description:
Primary Endpoints:
* Safety: Death or stroke in downstream territory to 180-days post-procedure
* Technical Success: Device placement success and ability to retain coils at the time of the index procedure
* Rate of aneurysm occlusion at Day zero (0) and 180 days
Additional Evaluations to 180-days and at 365-day follow up:
* Rate of aneurysm occlusion at 365 days
* Device movement or migration
* Stenosis
* Rate of incidence of new neurological deficits
* Complication rate (neurological and non-neurological)
Study:
NCT02312856
Study Brief:
Protocol Section:
NCT02312856